Literature DB >> 22422896

CNS involvement at the onset of primary hemophagocytic lymphohistiocytosis.

K Deiva1, N Mahlaoui, F Beaudonnet, G de Saint Basile, G Caridade, D Moshous, Y Mikaeloff, S Blanche, A Fischer, M Tardieu.   

Abstract

OBJECTIVES: To differentiate onset of CNS involvement in primary hemophagocytic lymphohistiocytosis (HLH) from that of other CNS inflammatory diseases and to identify early symptoms linked to abnormal cognitive outcome.
METHODS: Forty-six children with primary HLH who had neurologic evaluation within 2 weeks and brain MRI within 6 months of diagnosis were included. Initial symptoms, CSF study, brain MRI, and neurologic outcome were assessed. Brain MRIs were compared with those of 44 children with acute disseminated encephalomyelitis (ADEM).
RESULTS: At disease onset, 29 children (63%) had neurologic symptoms and 7 (15%) had microcephaly. Twenty-three (50%) children had abnormal CSF study, but only 15 (33%) had abnormal brain MRI. The latter showed that patients with HLH, unlike patients with ADEM, had symmetric periventricular lesions, without thalamic and brainstem involvement and with infrequent hyposignal intensity on T1. At the end of follow-up (3.6 ± 3.6 years), 17 of the 28 (61%) surviving patients had normal neurologic status, 5 (18%) had a severe neurologic outcome, and 6 (21%) had mild cognitive difficulties. Abnormal neurologic outcome was not influenced by age or type of genetic defect, but by the presence of neurologic symptoms, MRI lesions, or abnormal CSF study at onset. Early clinical and MRI symptoms may regress after treatment.
CONCLUSION: Neurologic symptoms are frequent at the onset of primary HLH and are mostly associated with abnormal CSF findings, but with normal brain MRI. In cases of abnormal brain MRI, the observed lesions differ from those of ADEM.

Entities:  

Mesh:

Year:  2012        PMID: 22422896     DOI: 10.1212/WNL.0b013e31824f800a

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

1.  Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.

Authors:  Kai Lehmberg; Kim E Nichols; Jan-Inge Henter; Michael Girschikofsky; Tatiana Greenwood; Michael Jordan; Ashish Kumar; Milen Minkov; Paul La Rosée; Sheila Weitzman
Journal:  Haematologica       Date:  2015-08       Impact factor: 9.941

2.  Hemophagocytic lymphohistiocytosis diagnosed by brain biopsy.

Authors:  Hee Young Ju; Che Ry Hong; Sung Jin Kim; Ji Won Lee; Hyery Kim; Hyoung Jin Kang; Kyung Duk Park; Hee Young Shin; Jong-Hee Chae; Ji Hoon Phi; Jung-Eun Cheon; Sung-Hye Park; Hyo Seop Ahn
Journal:  Korean J Pediatr       Date:  2015-09-21

3.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Maurizio Aricó; Itziar Astigarraga; R Maarten Egeler; Alexandra H Filipovich; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Scott Montgomery; Vasanta Nanduri; Diego Rosso; Jan-Inge Henter
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

4.  Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia.

Authors:  Hossein Esmaeilzadeh; Mohammad Hasan Bemanian; Mohammad Nabavi; Saba Arshi; Morteza Fallahpour; Ilka Fuchs; Udo zur Stadt; Klaus Warnatz; Sandra Ammann; Stephan Ehl; Kai Lehmberg; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-12-10       Impact factor: 8.317

5.  Recurrent subacute post-viral onset of ataxia associated with a PRF1 mutation.

Authors:  Cristina Dias; Allison McDonald; Murat Sincan; Rosemarie Rupps; Thomas Markello; Ramona Salvarinova; Rui F Santos; Kamal Menghrajani; Chidi Ahaghotu; Darren P Sutherland; Edgardo S Fortuno; Tobias R Kollmann; Michelle Demos; Jan M Friedman; David P Speert; William A Gahl; Cornelius F Boerkoel
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

Review 6.  Imaging in Pediatric Multiple Sclerosis : An Iconographic Review.

Authors:  Gonzalo Barraza; Kumaran Deiva; Béatrice Husson; Catherine Adamsbaum
Journal:  Clin Neuroradiol       Date:  2020-07-16       Impact factor: 3.649

7.  Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.

Authors:  Honghao Ma; Rui Zhang; Liping Zhang; Ang Wei; Xiaoxi Zhao; Ying Yang; Wei Liu; Zhigang Li; Maoquan Qin; Tianyou Wang
Journal:  Ann Hematol       Date:  2020-08-06       Impact factor: 3.673

8.  Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System.

Authors:  Isaac H Solomon; Hojun Li; Leslie A Benson; Lauren A Henderson; Barbara A Degar; Mark P Gorman; Christine N Duncan; Hart G Lidov; Sanda Alexandrescu
Journal:  J Neuropathol Exp Neurol       Date:  2018-12-01       Impact factor: 3.685

9.  Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Ida Hed Myrberg; Maurizio Aricó; Itziar Astigarraga; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Vasanta Nanduri; Diego A Rosso; Elena Sieni; Jacek Winiarski; Jan-Inge Henter
Journal:  Blood Adv       Date:  2020-08-11

10.  Cytomorphologic Features Found in Cerebrospinal Fluid Specimens of Hemophagocytic Lymphohistiocytosis Patients.

Authors:  Susan Shyu; Dragos Luca; Christopher J VandenBussche; Cheng-Ying Ho
Journal:  Am J Clin Pathol       Date:  2021-08-04       Impact factor: 2.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.